Stevanato Group Corp (STVN) Price to Earnings Ratio

Stevanato - graphic logo of issuer STVN

The current P/E ratio reflects the market valuation of Stevanato Group S.p.A. (STVN), whose revenues are based on the production of high-tech containers for biologics and insulin systems. The 4.90 level captures the current state of the asset, which possesses defensive qualities due to the inelastic demand for medical glass. The exceptional resilience of the business is ensured by the critical importance of its products for global vaccine manufacturers.

Stevanato Group (STVN) - P/E Multiple from 07/04/2022 to 11/14/2026

Analytical breakdowns for Stevanato Group S.p.A.

- price and consensus price forecast:
General company analysis:Stevanato Group SpA, STVN
Product sample of Stevanato Group S.p.A.

A P/E ratio of 4.90 determines the investment payback period via the ratio of market capitalization to net income, reflecting market expectations for business efficiency. By analyzing the P/E ratio dynamics of Stevanato Group S.p.A. (STVN), one can assess how cost optimization through raw glass outsourcing and IT quality control impacts final profitability and the fundamental value of the shares.

Analysis of competing companies

P/E Multiple Intuitive Surgical, Inc.|Price to Earnings Ratio DHR (Danaher Corp)|BDX (Becton, Dickinson and Company) - Company Value to Net Income|P/E Multiple STE (steris.com)|Business Payback Period westpharma.com (WST)|BAX - Price to Earnings Ratio|Business Payback Period Masimo Corp MASI|Teleflex Corp (TFX) - Price to Earnings Ratio|Price to Earnings Multiple MMSI|Price to Earnings Ratio envistaco.com|ICU Medical (ICUI) - Business Payback Period|Price to Earnings Ratio XRAY (DENTSPLY SIRONA Inc.)|Market Price to Net Income Ratio LMAT|Price to Earnings Ratio AtriCure Corp ATRC|Company Value to Net Income STAA|NAGE: Price to Earnings Ratio|ZIMV - P/E Multiple|AngioDynamics Inc (ANGO) - Price to Earnings Ratio|Price to Earnings Ratio Cerus|TKNO (teknova.com) - P/E Multiple|Market Cap to Earnings Monogram Orthopedics Inc. MGRM|Price to Earnings Ratio Sharps Tech (STSS)|InfuSystem Inc - Price to Earnings Multiple|Utah Medical Products - Price to Earnings Ratio|Market Price to Net Income Ratio KRMD (KORU Medical Systems)|NYXH - Price to Earnings Ratio|Business Payback Period Microbot Medical, Inc MBOT|Pro-Dex Corp (PDEX) - Price to Earnings Ratio|Market Cap to Net Income ZTEK (Zentek Ltd.)|Price to Earnings Ratio Elutia|Milestone Scientific Inc (MLSS) - Business Payback Period|Price to Earnings Ratio NXGL (NEXGEL, Inc.)|RVP (Retractable Technologies, Inc.) - Company Value to Net Income|Harvard Bioscience, Inc. - Price to Earnings Ratio|P/E Multiple femasys.com FEMY|MHUA: Price to Earnings Ratio|Business Payback Period predictive-oncology.com POAI|Callan JMB Inc (CJMB) - Price to Earnings Ratio|Price to Earnings Multiple ATRI|NURO (NeuroMetrix Inc) - P/E Multiple